AOBiome: New 30 Patient Study Of AOBiome's New Shelf-Stable Formulation Of Its Ammonia Oxidizing Bacteria (AOB) Shows Reduction Of Itch Levels In Both Pediatric And Adult Subjects Who Suffer From Eczema.
CAMBRIDGE, Mass., Aug. 17, 2021 /PRNewswire/ -- AOBiome Therapeutics, Inc. ('AOBiome'), a leading clinical-stage microbiome company focusing on in...
Read full article »
AOBiome focuses on developing skin care products that restore ammonia-oxidizing bacteria.
Read more